Publisher: Market Xcel
Category: Antisense & RNAi Technology
Category: Antisense & RNAi Technology
Antisense & RNAi Technology market research reports by Market Xcel
(2 reports matching your criteria)
-
Gene Editing Market Assessment, By Products and Services [Reagents and Consumables, Software and Systems, Services], By Technique [Knock-in, Knock-out, Gene Silencing, Others], By Method [Ex-vivo, In-vivo], By Technology [CRISPR, TALENs, ZFN, Antisense, Others], By Application [Genetic Engineering, Clinical Applications], By End-user [Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, CROs and CDMOs], By Region, Opportunities and Forecast, 2018-2032F
Global gene editing market is projected to witness a CAGR of 17.87% during the forecast period 2025-2032, growing from USD 9.01 billion in 2024 to USD 33.57 billion in 2032. The market's growth is supported by the rising applications of gene editing in various industries, the increasing prevalence o ... Read More
-
RNA Therapeutics Market Assessment, By Type [RNA Interference Therapeutics, mRNA Therapeutics, Antisense Oligonucleotide Therapeutics, Others], By Product [Vaccines, Drugs], By Indication [Rare Genetic Diseases/Hereditary Diseases, Infectious Diseases, Others], By End-user [Hospitals, Academic Research Centers, Contract Research Organizations, Others], By Region, Opportunities and Forecast, 2017-2031F
RNA Therapeutics Market Assessment, By Type [RNA Interference Therapeutics, mRNA Therapeutics, Antisense Oligonucleotide Therapeutics, Others], By Product [Vaccines, Drugs], By Indication [Rare Genetic Diseases/Hereditary Diseases, Infectious Diseases, Others], By End-user [Hospitals, Academic Resea ... Read More
Research Assistance
